Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
This study has been completed.
University of Alabama at Birmingham
First Posted: March 3, 2011
Last Update Posted: September 13, 2017
Susan G. Komen Breast Cancer Foundation
Daiichi Sankyo UK Ltd.
Triple Negative Breast Cancer Foundation
Information provided by (Responsible Party):
Andres Forero, University of Alabama at Birmingham